Australian scientists are working on new painkilling drugs that are more targeted and with fewer side effects for people living with debilitating and chronic pain.
The medicines, which target a molecule believed to affect how the human body senses pain, are being developed by the University of Queensland startup Cassowary Pharmaceuticals.
